Directory › Aenova
Aenova — Ratisbon
Ratisbon, Germany · CDMO
Site facts
- Company
- Aenova
- Name(s) in FDA data
- Haupt Pharma Amareg GmbH
- FEI number(s)
- 3008293991 (present in FDA Data Dashboard records for this name and city)
- Location (as in FDA data)
- Ratisbon, Germany
- Records matched
- 6 FDA inspections
- Most recent FDA inspection in dataset
- 26 Jul 2024 — VAI
Capabilities (from the company's website)
- Sterile fill-finish
…and granules Hardcapsules Film coated tablets Semisolids Gels Creams Pastes Ointments Non sterile Liquids Solutions Suspensions OEB 1-5, incl. narcotics and hormones Quality service Development…
- Highly potent (HPAPI)
…ds The Aenova Group site in Regensburg with its special environment is one of the leading HPAPI development, production and packaging facilities for high potent solids: Capsules, tablet…
- Oral solid dose
…he leading HPAPI development, production and packaging facilities for high potent solids: Capsules, tablets and film coated tablets From small to large scale (0,5 to 500kg) Covering comple…
- Oral liquids & semi-solids
…Germany Competence Center high potent solids (oncology) – conventional solids - specialty semisolids & liquids The Aenova Group site in Regensburg with its special environment is one of the…
- Clinical trial supply & packaging
…burg with its special environment is one of the leading HPAPI development, production and packaging facilities for high potent solids: Capsules, tablets and film coated tablets From small t…
- Formulation & process development
…ction: 3,506 m² Packaging: 3,966 m² Goods receipt and storage: 4,200 m² Analytics: 877 m² Formulation development/ clinical trials: 200 m² FTE: 363 Shifts: 15/5 Manufacturing Services Production of Solid…
Taken from the company's web page for this site. Source: https://www.aenova-group.com/en/company/manufacturing-sites/regensburg, checked 16 Oct 2026. Quoted text shows the wording each tag is based on.
Regulatory timeline
Newest first. Each entry links to the published source. Inspection classifications: NAI = no action indicated, VAI = voluntary action indicated, OAI = official action indicated (FDA definitions). Posted 483 citations are FDA's short summaries, not the full Form 483.
-
26 Jul 2024FDA inspection FDA inspection classified VAI
Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.
Source: FDA Data Dashboard – Inspections (FEI 3008293991, inspection ID 1274881)
-
07 Jun 2019FDA inspection FDA inspection classified VAI
Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.
Source: FDA Data Dashboard – Inspections (FEI 3008293991, inspection ID 1134674)
-
10 Nov 2017FDA inspection FDA inspection classified VAI
Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.
Source: FDA Data Dashboard – Inspections (FEI 3008293991, inspection ID 1038904)
-
26 Aug 2016FDA inspection FDA inspection classified VAI
Voluntary Action Indicated (VAI). Product type(s): Drugs, Veterinary. Project area(s): Drug Quality Assurance; Monitoring of Marketed Animal Drugs, Feed, and Devices.
Source: FDA Data Dashboard – Inspections (FEI 3008293991, inspection ID 986248)
-
22 Nov 2013FDA inspection FDA inspection classified NAI
No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.
Source: FDA Data Dashboard – Inspections (FEI 3008293991, inspection ID 857318)
-
18 May 2011FDA inspection FDA inspection classified NAI
No Action Indicated (NAI). Product type(s): Veterinary. Project area(s): Monitoring of Marketed Animal Drugs, Feed, and Devices; Pre-Approval Eval. of Animal Drugs and Food Additives.
Source: FDA Data Dashboard – Inspections (FEI 3008293991, inspection ID 727709)
This is a record of what regulators published, not a rating. Absence of a record here does not mean no record exists; see methodology for what we check and how records are matched.